drugset / Trial / NCT00094484

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

NCT00094484

Phase 3 Completed 400 enrolled Amgen
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of cinacalcet compared with placebo in patients with stage 3 and 4 Chronic Kidney Disease (CKD).

Timeline

Start
2004-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinacalcet Other / unclassified